InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: cabel post# 212607

Friday, 01/12/2018 1:38:57 PM

Friday, January 12, 2018 1:38:57 PM

Post# of 403482
Cabel, an anecdote about damage done with statistical significance.

Some years ago one fella (don't remember who and forgot to save the link) did a study about statistical power and statistical significance in early stage (p2) clinical trials. His conclusion:

Several probably efficacious drugs got short shrift and were abandoned because of too heavy emphasis on p value in small trials. His advice, if I remember, was either run larger trials if you can afford it or relax with p value.

So, there :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News